Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SOLARA ACTIVE PHARMA SCIENCES Gains 7%; BSE HEALTHCARE Index Down 0.0%
Wed, 26 Jun 12:20

SOLARA ACTIVE PHARMA SCIENCES Gains 7%; BSE HEALTHCARE Index Down 0.0%Image source: Kameleon007 /www.istockphoto.com

SOLARA ACTIVE PHARMA SCIENCES share price has zoomed 7% and is presently trading at Rs 488.2.

Meanwhile, the BSE HEALTHCARE index is at 36,728.4 .

Among the top gainers in the BSE HEALTHCARE index today are Abbott India (up 2.4%) and SUN PHARMA ADV. RES. (up 2.3%).

HIKAL CHEMIC (down 2.2%) and MAX HEALTHCARE INSTITUTE (down 2.0%) are among the top losers today.

Over the last one year, SOLARA ACTIVE PHARMA SCIENCES has moved up from Rs 345.0 to Rs 488.2, registering a gain of Rs 143.1 (up 41.5%).

On the other hand, the BSE HEALTHCARE index has moved up from 25,266.1 to 36,728.4, registering a gain of 45.4% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Cadila Healthcare (up 92.7%), Glenmark Pharma (up 90.9%) and GSK Pharma (up 83.5%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 78,492.5 (up 0.6%).

The top gainers among the BSE Sensex today are Ultratech Cement (up 3.3%) and Reliance Ind. (up 2.0%). The most traded stocks in the BSE Sensex are Tata Steel and ICICI Bank.

In the meantime, NSE Nifty is at 23,843.1 (up 0.5%). Ultratech Cement and Reliance Ind. are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 62,970.0 to 78,492.5, registering a gain of 15,522.5 points (up 24.7%).

SOLARA ACTIVE PHARMA SCIENCES Financial Update...

SOLARA ACTIVE PHARMA SCIENCES net profit fell 6912.0% YoY to Rs -2,555 million for the quarter ended March 2024, compared to a profit of Rs 38 million a year ago. Net sales declined 21.3% to Rs 2,994 million during the period as against Rs 3,806 million in January-March 2023.

For the year ended March 2023, SOLARA ACTIVE PHARMA SCIENCES reported 61.8% increase in net profit to Rs -223 million compared to net loss of Rs 583 million during FY22. Revenue of the company grew 13.8% to Rs 14,438 million during FY23.

The current Price to earnings ratio of SOLARA ACTIVE PHARMA SCIENCES, based on rolling 12 month earnings, stands at -4.1.


Equitymaster requests your view! Post a comment on "SOLARA ACTIVE PHARMA SCIENCES Gains 7%; BSE HEALTHCARE Index Down 0.0%". Click here!